Literature DB >> 1494078

Quality of life in the first 100 days after suspected acute myocardial infarction--a suitable trial endpoint?

J Rawles1, J Light, M Watt.   

Abstract

STUDY
OBJECTIVE: The aim was to determine the loss of quality of life following admission to hospital with suspected myocardial infarction.
DESIGN: The study involved a cohort of admissions, with interview and follow up for 100 days. Main outcome measures were the quality of life prior to admission and at each stage of convalescence, estimated using the Rosser-Kind matrix: the calculated number of quality adjusted days during a 100 d follow up period.
SETTING: The study took place in a teaching hospital in Scotland. PATIENTS: 206 patients were admitted with suspected acute myocardial infarction. Infarction was confirmed in 160 (Q wave infarcts 100, non-Q-wave infarcts 60), and unconfirmed in 46. MAIN
RESULTS: The quality of life scores before the suspected heart attack were similar for patients whose final diagnosis was Q wave infarction, non-Q-wave infarction, or non-infarction. Of the 160 patients with confirmed infarction, only 54 (34%) had regained their previous quality of life scores at the end of 100 days, compared with 26 of 46 (57%) patients with unconfirmed infarction (p < 0.01). The mean numbers of quality adjusted days lost to patients with Q wave infarction, non-Q-wave infarction, and non-infarction were 17.0, 12.4, and 5.9 respectively (infarction v non-infarction, p < 0.0001). Measurements of both quantity and quality of life contributed to these results.
CONCLUSIONS: The number of quality adjusted days lost after acute myocardial infarction is a practicable measurement that is relevant to patients' lives. It might be suitable as an outcome measure for clinical trials of thrombolytic therapy.

Entities:  

Mesh:

Year:  1992        PMID: 1494078      PMCID: PMC1059679          DOI: 10.1136/jech.46.6.612

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  16 in total

1.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

2.  Economics of coronary artery bypass grafting.

Authors:  A Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

3.  Editorial: Major changes made by Criteria Committee of the New York Heart Association.

Authors: 
Journal:  Circulation       Date:  1974-03       Impact factor: 29.690

4.  The measurement of hospital output.

Authors:  R M Rosser; V C Watts
Journal:  Int J Epidemiol       Date:  1972       Impact factor: 7.196

5.  Qualms about QALYs.

Authors:  A Smith
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

6.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes.

Authors:  D A Mahler; D H Weinberg; C K Wells; A R Feinstein
Journal:  Chest       Date:  1984-06       Impact factor: 9.410

7.  A quantitative approach to perceived health status: a validation study.

Authors:  S M Hunt; S P McKenna; J McEwen; E M Backett; J Williams; E Papp
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

8.  The Sickness Impact Profile: development and final revision of a health status measure.

Authors:  M Bergner; R A Bobbitt; W B Carter; B S Gilson
Journal:  Med Care       Date:  1981-08       Impact factor: 2.983

9.  Classification of disability and distress by ward nurses: a reliability study.

Authors:  T J Benson
Journal:  Int J Epidemiol       Date:  1978-12       Impact factor: 7.196

10.  Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction.

Authors:  K J Hogg; J D Gemmill; J M Burns; W K Lifson; A P Rae; F G Dunn; W S Hillis
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

View more
  7 in total

1.  Change in quality of life in the year following cardiac rehabilitation.

Authors:  J Müller-Nordhorn; M Kulig; S Binting; H Völler; H Gohlke; K Linde; S N Willich
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

2.  A cardiovascular extension of the Health Measurement Questionnaire.

Authors:  A J Martin; P P Glasziou; R J Simes
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

3.  Physical and mental component summaries score of the SF-36 in coronary patients.

Authors:  María Soto; Inmaculada Failde; Soledad Márquez; Encarnación Benítez; Ignacio Ramos; Antonio Barba; Fernando López
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

4.  Loss of quality adjusted days as a trial endpoint: effect of early thrombolytic treatment in suspected myocardial infarction. Grampion Region Early Anistreplase Trial (GREAT).

Authors:  J Rawles; J Light
Journal:  J Epidemiol Community Health       Date:  1993-10       Impact factor: 3.710

5.  Changes in Health Related Quality of Life 3 months after an acute coronary syndrome.

Authors:  Inmaculada I Failde; Maria M Soto
Journal:  BMC Public Health       Date:  2006-01-27       Impact factor: 3.295

Review 6.  Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease.

Authors:  T Nicholson; A McGuire; R Milne
Journal:  BMC Cardiovasc Disord       Date:  2001-10-15       Impact factor: 2.298

7.  Assessing response bias from missing quality of life data: the Heckman method.

Authors:  Anne E Sales; Mary E Plomondon; David J Magid; John A Spertus; John S Rumsfeld
Journal:  Health Qual Life Outcomes       Date:  2004-09-16       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.